299
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Discovery of CDK4 Inhibitors By Convolutional Neural Networks

, , , &
Pages 165-177 | Received 23 Sep 2018, Accepted 21 Nov 2018, Published online: 17 Dec 2018

References

  • Ghosh AK Gemma S . In : Structure-based design of drugs and other bioactive molecules tools and strategies . Wiley-VCH , Weinheim, Germany ( 2014 ).
  • Hansch C Maloney PP Fujita T Muir RM . Correlation of biological activity of phenoxyacetic acids with hammett substituent constants and partition coefficients . Nature194 ( 4824 ), 178 – 180 ( 1962 ).
  • Hansch C Fujita T . p-σ-π analysis. A method for the correlation of biological activity and chemical structure . J. Am. Chem. Soc.86 ( 8 ), 1616 – 1626 ( 1964 ).
  • Gawehn E Hiss JA Schneider G . Deep learning in drug discovery . Mol. Inform.35 , 3 – 14 ( 2016 ).
  • Chem H Engkvist O Wang Y Olivecrona M Blaschke T . The rise of deep learning in drug discovery . Drug Discov. Today23 ( 6 ), 1241 – 1250 ( 2018 ).
  • Hessler G Baringhaus KH . Artificial intelligence in drug design . Molecules23 ( 10 ), 2520 ( 2018 ).
  • Dana D Gadhiya SV St-Surin LG et al. Deep learning in drug discovery and medicine; scratching the surface . Molecules23 ( 9 ), 2384 ( 2018 ).
  • Zhong F Xing J Li X et al. Artificial intelligence in drug design . Sci. China Life Sci.61 ( 10 ), 1191 – 1204 ( 2018 ).
  • Ghasemi F Mehridehnavi A Pérez-Garrido A Pérez-Sánchez H . Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks . Drug Discov. Today23 ( 10 ), 1784 – 1790 ( 2018 ).
  • Duvenaud D Maclaurin D Aguilera-Iparraguirre J et al. Convolutional networks on graphs for learning molecular fingerprints . Arxiv 1509.09292 ( 2015 ).
  • Altae-Tran H Ramsundar B Pappu AS Pande V . Low data drug discovery with one-shot learning . ACS Cent. Sci.3 , 283 – 293 ( 2017 ).
  • Coley CW Barzilay R Green WH Jaakkola TS Jensen KF . Convolutional embedding of attributed molecular graphs for physical property prediction . J. Chem. Inf. Model.57 , 1757 – 1772 ( 2017 ).
  • Segler MHS Kogej T Tyrchan C Waller MP . Generating focused molecule libraries for drug discovery with recurrent neural networks . ACS Cent. Sci.4 , 120 – 131 ( 2018 ).
  • Gupta A Müller AT Huisman BJH Fuchs JA Schneider P Schneider G . Generative recurrent networks for de novo drug design . Mol. Inform.37 ( 1–2 ), 1700111 ( 2018 ).
  • Olivecrona M Blaschke T Engkvist O Chen H . Molecular de-dovo design through deep reinforcement learning . J. Cheminform.9 ( 1 ), 48 ( 2017 ).
  • Arshad L Haque MA Abbas Bukhari SN Jantan I . An overview of structure-activity relationship studies of curcumin analogs as antioxidant and anti-inflammatory agents . Future Med. Chem.9 ( 6 ), 605 – 626 ( 2017 ).
  • Lecun Y Bengio Y Hinton G . Deep learning . Nature521 ( 7553 ), 436 – 444 ( 2015 ).
  • Hezaveh YD Levasseur LP Marshall PJ . Fast automated analysis of strong gravitational lenses with convolutional neural networks . Nature548 ( 7669 ), 555 – 557 ( 2017 ).
  • Yang Z Huang Y Jiang Y Sun Y Zhang YJ Luo P . Clinical assistant diagnosis for electronic medical record based on convolutional neural network . Sci. Rep.8 ( 1 ), 6329 ( 2018 ).
  • Budach S Marsico A . Pysster: classification of biological sequences by learning sequence and structure motifs with convolutional neural networks . Bioinformatics34 ( 17 ), 3035 – 3037 ( 2018 ).
  • Goel S DeCristo MJ Watt AC et al. CDK4/6 inhibition triggers anti-tumour immunity . Nature548 ( 4668 ), 471 – 475 ( 2017 ).
  • Sherr CJ Roberts JM . CDK inhibitors: positive and negative regulators of G1-phase progression . Genes Dev.13 ( 12 ), 1501 – 1512 ( 1999 ).
  • Bathini Y Singh I Harvey PJ et al. 2-Aminoquinazoline inhibitors of cyclin-dependent kinases . Bioorg. Med. Chem. Lett.15 ( 17 ), 3881 – 3885 ( 2005 ).
  • Walker AJ Wedam S Amiri-Kordestani L et al. FDA approval of palbociclib in combination with fulvestrant for the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer . Clin. Cancer Res.22 ( 20 ), 4968 – 4972 ( 2016 ).
  • Loibl S Turner NC Ro J et al. Palbociclib combined with fulvestrant in premenopausal women with advanced breast cancer and prior progression on endocrine therapy: PALOMA-3 results . Oncologist22 ( 9 ), 1028 – 1038 ( 2017 ).
  • Martin CA Cullinane C Kirby L et al. Palbociclib synergizes with BRAF and MEK inhibitors in treatment naive melanoma but not after the development of BRAF inhibitor resistance . Int. J. Cancer142 ( 10 ), 2139 – 2152 ( 2018 ).
  • Xiao T Qi X Chen Y Jiang Y . Development of ligand-based big data deep neural network models for virtual screening of large compound libraries . Mol. Inform. ( 2018 ) ( In Press ).
  • Lenselink EB Ten Dijke N Bongers B et al. Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set . J. Cheminform.9 ( 1 ), 45 ( 2017 ).
  • Gaulton A Bellis LJ Bento AP et al. ChEMBL: a large-scale bioactivity database for drug discovery . Nucleic Acids Res.40 ( Database issue ), D1100 – D1107 ( 2012 ).
  • Abadi M Agarwal A Barham P et al. TensorFlow: large-scale machine learning on heterogeneous distributed systems . Arxiv 1603.04467 ( 2016 ).
  • Nair V Hinton GE . Rectified linear units improve restricted boltzmann machines . Presented at : 27th International Conference on Machine Learning . Haifa, Israel , 21–24 June 2010 .
  • Srivastava N Hinton G Krizhevsky A Sutskever I Salakhutdinov R . Dropout: a simple way to prevent neural networks from overfitting . J. Mach. Learn. Res.15 , 1929 – 1958 ( 2014 ).
  • Kingma DP Ba J . Adam: a method for stochastic optimization . Arxiv 1412.6980 ( 2014 ).
  • Bradley AP . The use of the area under the ROC curve in the evaluation of machine learning algorithms . Pattern Recogn.30 ( 7 ), 1145 – 1159 ( 1997 ).
  • Wu X Zhang X Liu C . Automated inference on sociopsychological impressions of attractive female faces . Arxiv 1612.04158 ( 2016 ).
  • Lu H Schulze-Gahmen U . Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition . J. Med. Chem.49 ( 13 ), 3826 – 3831 ( 2006 ).
  • Choi SJ Lee JE Jeong SY et al. 5,5′-substituted indirubin-3′-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity . J. Med. Chem.53 ( 9 ), 3696 – 3706 ( 2010 ).
  • Goh GB Siegel C Vishnu A Hodas N Baker N . How much chemistry does a deep neural network need to know to make accurate predictions?Arxiv 1710.02238 ( 2018 ).
  • Goh GB Siegel C Vishnu A Hodas N Baker N . Chemception: a deep neural network with minimal chemistry knowledge matches the performance of expert-developed QSAR/QSPR models . Arxiv 1706.06689 ( 2017 ).
  • Ching T Himmelstein DS Beaulieu-Jones BK et al. Opportunities and obstacles for deep learning in biology and medicine . J. R. Soc. Interface15 ( 141 ), 20170387 ( 2018 ).
  • Wallach I Heifets A . Most ligand-based classification benchmarks reward memorization rather than generalization . J. Chem. Inf. Model.58 ( 5 ), 916 – 932 ( 2018 ).
  • Krizhevsky A Sutskever I Hinton GE . ImageNet classification with deep convolutional neural networks . Presented at : 26th Annual Conference on Neural Information Processing Systems 2012 . Lake Tahoe, NV, USA , 3–6 December 2012 .
  • Zeiler MD Fergus R . Visualizing and understanding convolutional networks . Arxiv 1311.2901 ( 2013 ).
  • Ragoza M Hochuli J Idrobo E Sunseri J Koes DR . Protein-ligand scoring with convolutional neural networks . J. Chem. Inf. Model.57 ( 4 ), 942 – 957 ( 2017 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.